Stock Track | Belite Bio Soars 5.43% as Maxim Group Boosts Price Target to $140

Stock Track

11/12

Belite Bio, Inc. (NASDAQ: BLTE) saw its stock surge 5.43% in pre-market trading on Wednesday, following a significant price target upgrade from Maxim Group. The healthcare company's shares reacted positively to the analysts' increased confidence in its future prospects.

Maxim Group, a well-known financial services firm, raised its price target for Belite Bio to $140 from the previous $110. This represents a substantial 27% increase in the projected value of the company's stock. The upgrade suggests that Maxim Group analysts have become more optimistic about Belite Bio's growth potential and market position.

While specific reasons for the price target increase were not provided in the available news, such upgrades are typically based on factors like improved financial performance, promising drug development progress, or positive industry trends. Investors appear to be responding favorably to this vote of confidence from Maxim Group, as reflected in the pre-market stock movement.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1140977509"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1140977509\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1140977509?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 22:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1140977509","market":"nz","top_or_hot":-1,"title":"Stock Track | Belite Bio Soars 5.43% as Maxim Group Boosts Price Target to $140","media":"Stock Track","content":"<p>Belite Bio, Inc. (NASDAQ: BLTE) saw its stock surge 5.43% in pre-market trading on Wednesday, following a significant price target upgrade from Maxim Group. The healthcare company's shares reacted positively to the analysts' increased confidence in its future prospects.</p>\n\n<p>Maxim Group, a well-known financial services firm, raised its price target for Belite Bio to $140 from the previous $110. This represents a substantial 27% increase in the projected value of the company's stock. The upgrade suggests that Maxim Group analysts have become more optimistic about Belite Bio's growth potential and market position.</p>\n\n<p>While specific reasons for the price target increase were not provided in the available news, such upgrades are typically based on factors like improved financial performance, promising drug development progress, or positive industry trends. Investors appear to be responding favorably to this vote of confidence from Maxim Group, as reflected in the pre-market stock movement.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Belite Bio Soars 5.43% as Maxim Group Boosts Price Target to $140</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Belite Bio Soars 5.43% as Maxim Group Boosts Price Target to $140\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-11-12 22:34</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Belite Bio, Inc. (NASDAQ: BLTE) saw its stock surge 5.43% in pre-market trading on Wednesday, following a significant price target upgrade from Maxim Group. The healthcare company's shares reacted positively to the analysts' increased confidence in its future prospects.</p>\n\n<p>Maxim Group, a well-known financial services firm, raised its price target for Belite Bio to $140 from the previous $110. This represents a substantial 27% increase in the projected value of the company's stock. The upgrade suggests that Maxim Group analysts have become more optimistic about Belite Bio's growth potential and market position.</p>\n\n<p>While specific reasons for the price target increase were not provided in the available news, such upgrades are typically based on factors like improved financial performance, promising drug development progress, or positive industry trends. Investors appear to be responding favorably to this vote of confidence from Maxim Group, as reflected in the pre-market stock movement.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BLTE","symbol_name":"Belite Bio, Inc.","start_time":0,"source_url":"","article_id":"1140977509","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1140977509","pubTimestamp":1762958079,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Belite Bio, Inc. (NASDAQ: BLTE) saw its stock surge 5.43% in pre-market trading on Wednesday, following a significant price target upgrade from Maxim Group. The healthcare company's shares reacted...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BLTE":"Belite Bio, Inc."},"translate_title":"个股追踪|美信集团上调目标价至140美元贝利特生物大涨5.43%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLTE":1},"content_text":"Belite Bio, Inc. (NASDAQ: BLTE) saw its stock surge 5.43% in pre-market trading on Wednesday, following a significant price target upgrade from Maxim Group. The healthcare company's shares reacted positively to the analysts' increased confidence in its future prospects.\nMaxim Group, a well-known financial services firm, raised its price target for Belite Bio to $140 from the previous $110. This represents a substantial 27% increase in the projected value of the company's stock. The upgrade suggests that Maxim Group analysts have become more optimistic about Belite Bio's growth potential and market position.\nWhile specific reasons for the price target increase were not provided in the available news, such upgrades are typically based on factors like improved financial performance, promising drug development progress, or positive industry trends. Investors appear to be responding favorably to this vote of confidence from Maxim Group, as reflected in the pre-market stock movement.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}